
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia
Jean‐Baptiste Demoulin, Violaine Havelange
Journal of Blood Medicine (2013), pp. 111-111
Open Access | Times Cited: 18
Jean‐Baptiste Demoulin, Violaine Havelange
Journal of Blood Medicine (2013), pp. 111-111
Open Access | Times Cited: 18
Showing 18 citing articles:
PDGF receptor signaling networks in normal and cancer cells
Jean‐Baptiste Demoulin, Ahmed Essaghir
Cytokine & Growth Factor Reviews (2014) Vol. 25, Iss. 3, pp. 273-283
Closed Access | Times Cited: 225
Jean‐Baptiste Demoulin, Ahmed Essaghir
Cytokine & Growth Factor Reviews (2014) Vol. 25, Iss. 3, pp. 273-283
Closed Access | Times Cited: 225
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib
Chan Y. Cheah, Kate Burbury, Jane F. Apperley, et al.
Blood (2014) Vol. 123, Iss. 23, pp. 3574-3577
Open Access | Times Cited: 128
Chan Y. Cheah, Kate Burbury, Jane F. Apperley, et al.
Blood (2014) Vol. 123, Iss. 23, pp. 3574-3577
Open Access | Times Cited: 128
PDGF receptor mutations in human diseases
Emilie M. Guérit, Florence A. Arts, Guillaume Dachy, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 8, pp. 3867-3881
Closed Access | Times Cited: 91
Emilie M. Guérit, Florence A. Arts, Guillaume Dachy, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 8, pp. 3867-3881
Closed Access | Times Cited: 91
Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency
Dominick Latrémouille-Viau, Annie Guérin, Patrick Gagnon‐Sanschagrin, et al.
Journal of Managed Care & Specialty Pharmacy (2017) Vol. 23, Iss. 2, pp. 214-224
Open Access | Times Cited: 37
Dominick Latrémouille-Viau, Annie Guérin, Patrick Gagnon‐Sanschagrin, et al.
Journal of Managed Care & Specialty Pharmacy (2017) Vol. 23, Iss. 2, pp. 214-224
Open Access | Times Cited: 37
A concise, practical guide to diagnostic assessment for mast cell activation disease
Lawrence B. Afrin, Gerhard J. Molderings
World Journal of Hepatology (2014) Vol. 3, Iss. 1, pp. 1-17
Closed Access | Times Cited: 31
Lawrence B. Afrin, Gerhard J. Molderings
World Journal of Hepatology (2014) Vol. 3, Iss. 1, pp. 1-17
Closed Access | Times Cited: 31
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes
Stefania Stella, Michele Massimino, Livia Manzella, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 486-486
Open Access | Times Cited: 17
Stefania Stella, Michele Massimino, Livia Manzella, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 486-486
Open Access | Times Cited: 17
Identification of a novel fusion TBL1XR1–PDGFRB in a patient with acute myeloid leukemia harboring the DEK–NUP214 fusion and clinical response to dasatinib
Paulo Vidal Campregher, Nathalia da Silva Halley, Gabriela Amaral Vieira, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 58, Iss. 12, pp. 2969-2972
Closed Access | Times Cited: 19
Paulo Vidal Campregher, Nathalia da Silva Halley, Gabriela Amaral Vieira, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 58, Iss. 12, pp. 2969-2972
Closed Access | Times Cited: 19
Detection of a PDGFRB fusion in refractory CMML without eosinophilia: A case for broad spectrum tumor profiling
Gillian C. Bell, Eric Padron
Leukemia Research Reports (2015) Vol. 4, Iss. 2, pp. 70-71
Open Access | Times Cited: 11
Gillian C. Bell, Eric Padron
Leukemia Research Reports (2015) Vol. 4, Iss. 2, pp. 70-71
Open Access | Times Cited: 11
The Role of Eosinophils in Immunotherapy
Joseph Cafone, Melanie A. Ruffner, Jonathan M. Spergel
Current Allergy and Asthma Reports (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Joseph Cafone, Melanie A. Ruffner, Jonathan M. Spergel
Current Allergy and Asthma Reports (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Apoptosis of Eosinophil Granulocytes
Martina Zustakova, Lucie Kratochvílová, Petr Sláma
Biology (2020) Vol. 9, Iss. 12, pp. 457-457
Open Access | Times Cited: 6
Martina Zustakova, Lucie Kratochvílová, Petr Sláma
Biology (2020) Vol. 9, Iss. 12, pp. 457-457
Open Access | Times Cited: 6
The role of eosinophils in immunotherapy
Joseph Cafone, Melanie A. Ruffner, Jonathan M. Spergel
Current Opinion in Allergy and Clinical Immunology (2020) Vol. 20, Iss. 2, pp. 194-201
Open Access | Times Cited: 6
Joseph Cafone, Melanie A. Ruffner, Jonathan M. Spergel
Current Opinion in Allergy and Clinical Immunology (2020) Vol. 20, Iss. 2, pp. 194-201
Open Access | Times Cited: 6
Section II: Hematolymphoid malignancies
Linsheng Zhang, Michael R. Rossi, Kevin E. Fisher
Current Problems in Cancer (2014) Vol. 38, Iss. 5, pp. 159-174
Closed Access | Times Cited: 3
Linsheng Zhang, Michael R. Rossi, Kevin E. Fisher
Current Problems in Cancer (2014) Vol. 38, Iss. 5, pp. 159-174
Closed Access | Times Cited: 3
A rare case of myeloproliferative disease with t(8;13)(p11;q12) associated with eosinophilia and lymphadenopathy
Nikolay Tsyba, Anna Turkina, Ekaterina Chelysheva, et al.
Terapevticheskii arkhiv (2016) Vol. 88, Iss. 7, pp. 98-98
Open Access | Times Cited: 2
Nikolay Tsyba, Anna Turkina, Ekaterina Chelysheva, et al.
Terapevticheskii arkhiv (2016) Vol. 88, Iss. 7, pp. 98-98
Open Access | Times Cited: 2
Phosflow assessment of PDGFRA phosphorylation state: A guide for tyrosine kinase inhibitor targeted therapy in hypereosinophilia patients
Reza Ranjbaran, Mojdeh Abbasi, Gholamreza Rafiei Dehbidi, et al.
Cytometry Part A (2021) Vol. 99, Iss. 8, pp. 784-792
Open Access | Times Cited: 2
Reza Ranjbaran, Mojdeh Abbasi, Gholamreza Rafiei Dehbidi, et al.
Cytometry Part A (2021) Vol. 99, Iss. 8, pp. 784-792
Open Access | Times Cited: 2
Polycyclic rash with persistent eosinophilia
Lauren E. Merz, Mitchell H. Rubenstein, Aric Parnes
JAAD Case Reports (2021) Vol. 12, pp. 8-11
Open Access | Times Cited: 1
Lauren E. Merz, Mitchell H. Rubenstein, Aric Parnes
JAAD Case Reports (2021) Vol. 12, pp. 8-11
Open Access | Times Cited: 1
A case of myeloid neoplasm with FIP1L1–PDGFRA rearrangement without marked peripheral blood eosinophilia
Jing Wang, Qiguo Zhang, Hui Zeng, et al.
Pharmacogenomics (2015) Vol. 17, Iss. 2, pp. 99-102
Closed Access
Jing Wang, Qiguo Zhang, Hui Zeng, et al.
Pharmacogenomics (2015) Vol. 17, Iss. 2, pp. 99-102
Closed Access
Myeloid/Lymphoid Neoplasms with ETV6::PDGFRB Fusion Gene: A Rare Case of Poor Response to Imatinib and Possible Transformation Mechanisms from Myeloid Neoplasms of Bone Marrow to T-Cell Lymphoblastic Lymphoma Invasion in Lymph Nodes
Yang Gou, Yongjie Tang, Shuiqing Liu, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5163-5170
Open Access
Yang Gou, Yongjie Tang, Shuiqing Liu, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5163-5170
Open Access